主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management Company | 是 | 2341.93万 | 15.11% | 新增 | 新增 | -- |
| 2 | FMR LLC | 是 | 2238.78万 | 14.44% | 新增 | 新增 | -- |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | 是 | 2142.76万 | 13.82% | 新增 | 新增 | -- |
| 4 | 普信投资公司 | 是 | 1646.00万 | 10.62% | 新增 | 新增 | -- |
| 5 | 领航集团有限公司 | 是 | 1287.06万 | 8.30% | 新增 | 新增 | -- |
| 6 | 贝莱德集团公司 | 是 | 1056.83万 | 6.82% | 新增 | 新增 | -- |
| 7 | Vanguard Specialized Funds - Vanguard Health Care Fund | 是 | 906.92万 | 5.85% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-12-03 | Hopkinson Craig C. |
|
6.95 | 19.34 | 是 | EVP R&D, Chief Medical Officer |
| 2025-12-03 | Hopkinson Craig C. |
|
6.57 | 30.00 | 是 | EVP R&D, Chief Medical Officer |
| 2025-12-01 | Hopkinson Craig C. |
|
6.57 | 29.30 | 是 | EVP R&D, Chief Medical Officer |
| 2025-11-03 | Hopkinson Craig C. |
|
7.87 | 19.34 | 是 | EVP R&D, Chief Medical Officer |
| 2025-11-03 | Hopkinson Craig C. |
|
6.97 | 30.38 | 是 | EVP R&D, Chief Medical Officer |
| 2025-10-15 | Hopkinson Craig C. |
|
8.27 | 19.34 | 是 | EVP R&D, Chief Medical Officer |
| 2025-10-15 | Hopkinson Craig C. |
|
7.37 | 31.53 | 是 | EVP R&D, Chief Medical Officer |
| 2025-08-03 | Gaffin David Joseph |
|
20.63 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-08-03 | Gaffin David Joseph |
|
20.54 | 26.55 | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-06-09 | Nichols Christian Todd |
|
8.95 | 31.95 | 是 | SVP, Chief Commercial Officer |
| 2025-06-09 | Nichols Christian Todd |
|
8.62 | 31.09 | 是 | SVP, Chief Commercial Officer |
| 2025-06-08 | Wright Christopher I |
|
2.38 | -- | 是 | -- |
| 2025-06-08 | Wright Christopher I |
|
2.30 | 31.71 | 是 | -- |
| 2025-05-31 | Cooke Shane |
|
10.37 | 30.61 | 是 | -- |
| 2025-05-31 | Cooke Shane |
|
10.79 | -- | 是 | -- |
| 2025-05-31 | GAYNOR RICHARD |
|
3.11 | 30.61 | 是 | -- |
| 2025-05-31 | GAYNOR RICHARD |
|
3.30 | -- | 是 | -- |
| 2025-05-31 | LAURENCIN CATO T |
|
3.10 | -- | 是 | -- |
| 2025-05-31 | LAURENCIN CATO T |
|
2.91 | 30.61 | 是 | -- |
| 2025-05-31 | Lurker Nancy |
|
1.26 | -- | 是 | -- |
| 2025-05-31 | Lurker Nancy |
|
1.07 | 30.61 | 是 | -- |
| 2025-05-31 | Wright Christopher I |
|
2.24 | -- | 是 | -- |
| 2025-05-31 | Wright Christopher I |
|
2.05 | 30.61 | 是 | -- |
| 2025-05-31 | Wilson Frank Anders |
|
3.30 | -- | 是 | -- |
| 2025-05-31 | Wilson Frank Anders |
|
3.11 | 30.61 | 是 | -- |
| 2025-05-31 | snyderman nancy lynn MD |
|
1.27 | -- | 是 | -- |
| 2025-05-31 | snyderman nancy lynn MD |
|
1.07 | 30.61 | 是 | -- |
| 2025-05-31 | MCKEON BRIAN P |
|
3.58 | -- | 是 | -- |
| 2025-05-31 | MCKEON BRIAN P |
|
3.39 | 30.61 | 是 | -- |
| 2025-04-11 | Lurker Nancy |
|
0.23 | -- | 是 | -- |
| 2025-04-11 | Lurker Nancy |
|
0.18 | 27.00 | 是 | -- |
| 2025-04-11 | Lurker Nancy |
|
0.55 | -- | 是 | -- |
| 2025-04-11 | Lurker Nancy |
|
0.46 | 27.00 | 是 | -- |
| 2025-02-26 | Gaffin David Joseph |
|
20.73 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-26 | Gaffin David Joseph |
|
20.43 | 34.80 | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-26 | Hopkinson Craig C. |
|
8.08 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-26 | Hopkinson Craig C. |
|
7.77 | 34.80 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-26 | Parisi Samuel Joseph |
|
1.05 | -- | 是 | VP, Finance (Interim PAO) |
| 2025-02-26 | Parisi Samuel Joseph |
|
0.97 | 34.80 | 是 | VP, Finance (Interim PAO) |
| 2025-02-26 | Parisi Samuel Joseph |
|
0.77 | 34.00 | 是 | VP, Finance (Interim PAO) |
| 2025-02-26 | Nichols Christian Todd |
|
9.53 | -- | 是 | SVP, Chief Commercial Officer |
| 2025-02-26 | Nichols Christian Todd |
|
9.29 | 34.80 | 是 | SVP, Chief Commercial Officer |
| 2025-02-26 | Jackson Blair Curtis |
|
20.51 | -- | 是 | EVP, Chief Operating Officer |
| 2025-02-26 | Jackson Blair Curtis |
|
20.14 | 34.80 | 是 | EVP, Chief Operating Officer |
| 2025-02-26 | Brown Iain Michael |
|
15.07 | -- | 是 | SVP, Chief Financial Officer |
| 2025-02-26 | Brown Iain Michael |
|
14.82 | 34.80 | 是 | SVP, Chief Financial Officer |
| 2025-02-22 | Brown Iain Michael |
|
14.50 | -- | 是 | SVP, Chief Financial Officer |
| 2025-02-22 | Brown Iain Michael |
|
14.18 | 35.32 | 是 | SVP, Chief Financial Officer |
| 2025-02-22 | Brown Iain Michael |
|
14.77 | -- | 是 | SVP, Chief Financial Officer |
| 2025-02-22 | Brown Iain Michael |
|
14.51 | 35.32 | 是 | SVP, Chief Financial Officer |
| 2025-02-22 | Gaffin David Joseph |
|
19.95 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-22 | Gaffin David Joseph |
|
19.62 | 35.32 | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-22 | Gaffin David Joseph |
|
20.39 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-22 | Gaffin David Joseph |
|
20.04 | 35.32 | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-22 | Jackson Blair Curtis |
|
19.62 | -- | 是 | EVP, Chief Operating Officer |
| 2025-02-22 | Jackson Blair Curtis |
|
19.19 | 35.32 | 是 | EVP, Chief Operating Officer |
| 2025-02-22 | Jackson Blair Curtis |
|
20.06 | -- | 是 | EVP, Chief Operating Officer |
| 2025-02-22 | Jackson Blair Curtis |
|
19.67 | 35.32 | 是 | EVP, Chief Operating Officer |
| 2025-02-22 | Parisi Samuel Joseph |
|
1.08 | -- | 是 | VP, Finance (Interim PAO) |
| 2025-02-22 | Parisi Samuel Joseph |
|
0.77 | 35.26 | 是 | VP, Finance (Interim PAO) |
| 2025-02-22 | Parisi Samuel Joseph |
|
0.98 | 35.32 | 是 | VP, Finance (Interim PAO) |
| 2025-02-22 | Parisi Samuel Joseph |
|
1.21 | -- | 是 | VP, Finance (Interim PAO) |
| 2025-02-22 | Parisi Samuel Joseph |
|
1.15 | 35.32 | 是 | VP, Finance (Interim PAO) |
| 2025-02-22 | Hopkinson Craig C. |
|
7.51 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-22 | Hopkinson Craig C. |
|
6.96 | 35.32 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-22 | Hopkinson Craig C. |
|
7.73 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-22 | Hopkinson Craig C. |
|
7.39 | 35.32 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-22 | Nichols Christian Todd |
|
8.95 | -- | 是 | SVP, Chief Commercial Officer |
| 2025-02-22 | Nichols Christian Todd |
|
8.63 | 35.32 | 是 | SVP, Chief Commercial Officer |
| 2025-02-22 | Nichols Christian Todd |
|
9.27 | -- | 是 | SVP, Chief Commercial Officer |
| 2025-02-22 | Nichols Christian Todd |
|
8.99 | 35.32 | 是 | SVP, Chief Commercial Officer |
| 2025-02-18 | Nichols Christian Todd |
|
8.42 | -- | 是 | SVP, Chief Commercial Officer |
| 2025-02-18 | Nichols Christian Todd |
|
8.24 | 35.90 | 是 | SVP, Chief Commercial Officer |
| 2025-02-18 | Parisi Samuel Joseph |
|
0.98 | -- | 是 | VP, Finance (Interim PAO) |
| 2025-02-18 | Parisi Samuel Joseph |
|
0.90 | 35.90 | 是 | VP, Finance (Interim PAO) |
| 2025-02-18 | Parisi Samuel Joseph |
|
0.77 | 35.69 | 是 | VP, Finance (Interim PAO) |
| 2025-02-18 | Gaffin David Joseph |
|
19.49 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-18 | Gaffin David Joseph |
|
19.20 | 35.90 | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-18 | Brown Iain Michael |
|
13.97 | -- | 是 | SVP, Chief Financial Officer |
| 2025-02-18 | Brown Iain Michael |
|
13.79 | 35.90 | 是 | SVP, Chief Financial Officer |
| 2025-02-18 | Hopkinson Craig C. |
|
6.68 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-18 | Hopkinson Craig C. |
|
6.28 | 35.90 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-18 | Jackson Blair Curtis |
|
19.04 | -- | 是 | EVP, Chief Operating Officer |
| 2025-02-18 | Jackson Blair Curtis |
|
18.65 | 35.90 | 是 | EVP, Chief Operating Officer |
| 2025-02-12 | Hopkinson Craig C. |
|
9.10 | 32.69 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-12 | Hopkinson Craig C. |
|
5.79 | 33.27 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-12 | Hopkinson Craig C. |
|
16.67 | 31.93 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-12 | Hopkinson Craig C. |
|
15.12 | 20.03 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-12 | Hopkinson Craig C. |
|
26.28 | 19.34 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-12 | Hopkinson Craig C. |
|
20.23 | 24.59 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-12 | Hopkinson Craig C. |
|
16.67 | 34.02 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-12 | Hopkinson Craig C. |
|
5.79 | 36.02 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-06 | Brown Iain Michael |
|
13.34 | 31.39 | 是 | SVP, Chief Financial Officer |
| 2025-02-06 | POPS RICHARD F |
|
137.03 | -- | 是 | Director and CEO, Alkermes plc |
| 2025-02-06 | POPS RICHARD F |
|
129.04 | 31.39 | 是 | Director and CEO, Alkermes plc |
| 2025-02-06 | Brown Iain Michael |
|
14.09 | -- | 是 | SVP, Chief Financial Officer |
| 2025-02-06 | Gaffin David Joseph |
|
19.83 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-06 | Gaffin David Joseph |
|
18.85 | 31.39 | 是 | EVP, CLO, Alkermes, Inc. |
| 2025-02-06 | Hopkinson Craig C. |
|
7.87 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-06 | Hopkinson Craig C. |
|
6.36 | 31.39 | 是 | EVP R&D, Chief Medical Officer |
| 2025-02-06 | Jackson Blair Curtis |
|
19.22 | -- | 是 | EVP, Chief Operating Officer |
| 2025-02-06 | Jackson Blair Curtis |
|
18.15 | 31.39 | 是 | EVP, Chief Operating Officer |
| 2025-02-06 | Nichols Christian Todd |
|
8.53 | -- | 是 | SVP, Chief Commercial Officer |
| 2025-02-06 | Nichols Christian Todd |
|
7.79 | 31.39 | 是 | SVP, Chief Commercial Officer |
| 2025-01-30 | Hopkinson Craig C. |
|
7.67 | 20.03 | 是 | EVP R&D, Chief Medical Officer |
| 2025-01-30 | Hopkinson Craig C. |
|
10.33 | 19.34 | 是 | EVP R&D, Chief Medical Officer |
| 2025-01-30 | Hopkinson Craig C. |
|
12.69 | 24.59 | 是 | EVP R&D, Chief Medical Officer |
| 2025-01-30 | Hopkinson Craig C. |
|
14.52 | 26.82 | 是 | EVP R&D, Chief Medical Officer |
| 2025-01-30 | Hopkinson Craig C. |
|
4.43 | 32.05 | 是 | EVP R&D, Chief Medical Officer |
| 2024-12-09 | Hopkinson Craig C. |
|
7.22 | 20.03 | 是 | EVP R&D, Chief Medical Officer |
| 2024-12-09 | Hopkinson Craig C. |
|
8.43 | 19.34 | 是 | EVP R&D, Chief Medical Officer |
| 2024-12-09 | Hopkinson Craig C. |
|
9.63 | 24.59 | 是 | EVP R&D, Chief Medical Officer |
| 2024-12-09 | Hopkinson Craig C. |
|
10.87 | 26.82 | 是 | EVP R&D, Chief Medical Officer |
| 2024-12-09 | Hopkinson Craig C. |
|
4.76 | 32.07 | 是 | EVP R&D, Chief Medical Officer |
| 2024-12-08 | LAURENCIN CATO T |
|
2.40 | -- | 是 | -- |
| 2024-12-08 | LAURENCIN CATO T |
|
2.30 | 31.46 | 是 | -- |
| 2024-12-08 | LAURENCIN CATO T |
|
2.57 | 22.52 | 是 | -- |
| 2024-12-08 | LAURENCIN CATO T |
|
2.30 | 31.85 | 是 | -- |
| 2024-12-05 | Hopkinson Craig C. |
|
5.97 | 31.50 | 是 | EVP R&D, Chief Medical Officer |
| 2024-12-04 | Hopkinson Craig C. |
|
6.90 | 30.77 | 是 | EVP R&D, Chief Medical Officer |
| 2024-11-27 | Nichols Christian Todd |
|
6.07 | 29.15 | 是 | SVP, Chief Commercial Officer |
| 2024-11-11 | Hopkinson Craig C. |
|
14.23 | 20.03 | 是 | EVP R&D, Chief Medical Officer |
| 2024-11-11 | Hopkinson Craig C. |
|
8.33 | 30.08 | 是 | EVP R&D, Chief Medical Officer |
| 2024-11-06 | Hopkinson Craig C. |
|
9.92 | 29.53 | 是 | EVP R&D, Chief Medical Officer |
| 2024-08-03 | Gaffin David Joseph |
|
16.68 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-08-03 | Gaffin David Joseph |
|
16.59 | 27.72 | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-06-29 | Daglio David Angelo Jr. |
|
2.92 | -- | 是 | -- |
| 2024-06-29 | Daglio David Angelo Jr. |
|
2.78 | 24.10 | 是 | -- |
| 2024-06-29 | Cooke Shane |
|
10.31 | -- | 是 | -- |
| 2024-06-29 | Cooke Shane |
|
9.99 | 24.10 | 是 | -- |
| 2024-06-29 | Alva Emily Peterson |
|
2.88 | -- | 是 | -- |
| 2024-06-29 | Alva Emily Peterson |
|
2.73 | 24.10 | 是 | -- |
| 2024-06-29 | Wright Christopher I |
|
1.59 | -- | 是 | -- |
| 2024-06-29 | Wright Christopher I |
|
1.44 | 24.10 | 是 | -- |
| 2024-06-29 | Wilson Frank Anders |
|
2.65 | -- | 是 | -- |
| 2024-06-29 | Wilson Frank Anders |
|
2.50 | 24.10 | 是 | -- |
| 2024-06-29 | snyderman nancy lynn MD |
|
0.46 | 24.10 | 是 | -- |
| 2024-06-29 | snyderman nancy lynn MD |
|
0.61 | -- | 是 | -- |
| 2024-06-29 | LAURENCIN CATO T |
|
2.13 | -- | 是 | -- |
| 2024-06-29 | LAURENCIN CATO T |
|
1.98 | 24.10 | 是 | -- |
| 2024-06-29 | MCKEON BRIAN P |
|
2.92 | -- | 是 | -- |
| 2024-06-29 | MCKEON BRIAN P |
|
2.78 | 24.10 | 是 | -- |
| 2024-06-29 | GAYNOR RICHARD |
|
2.65 | -- | 是 | -- |
| 2024-06-29 | GAYNOR RICHARD |
|
2.50 | 24.10 | 是 | -- |
| 2024-06-09 | Alva Emily Peterson |
|
2.36 | -- | 是 | -- |
| 2024-06-09 | Alva Emily Peterson |
|
2.27 | 23.91 | 是 | -- |
| 2024-06-08 | Wright Christopher I |
|
0.98 | 23.91 | 是 | -- |
| 2024-06-08 | Wright Christopher I |
|
1.06 | -- | 是 | -- |
| 2024-03-18 | Nichols Christian Todd |
|
6.59 | 28.10 | 是 | SVP, Chief Commercial Officer |
| 2024-02-23 | Hopkinson Craig C. |
|
11.31 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-23 | Hopkinson Craig C. |
|
10.97 | 29.57 | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-23 | Jackson Blair Curtis |
|
16.17 | -- | 是 | EVP, Chief Operating Officer |
| 2024-02-23 | Jackson Blair Curtis |
|
15.78 | 29.57 | 是 | EVP, Chief Operating Officer |
| 2024-02-23 | LANDINE MICHAEL J |
|
28.35 | -- | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-23 | LANDINE MICHAEL J |
|
28.17 | 29.57 | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-23 | Brown Iain Michael |
|
11.89 | -- | 是 | SVP, Chief Financial Officer |
| 2024-02-23 | Brown Iain Michael |
|
11.63 | 29.57 | 是 | SVP, Chief Financial Officer |
| 2024-02-23 | Gaffin David Joseph |
|
16.82 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-23 | Gaffin David Joseph |
|
16.48 | 29.57 | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-23 | Nichols Christian Todd |
|
7.92 | -- | 是 | SVP, Chief Commercial Officer |
| 2024-02-23 | Nichols Christian Todd |
|
7.63 | 29.57 | 是 | SVP, Chief Commercial Officer |
| 2024-02-23 | Parisi Samuel Joseph |
|
0.77 | 29.65 | 是 | VP, Finance (Interim PAO) |
| 2024-02-23 | Parisi Samuel Joseph |
|
1.09 | -- | 是 | VP, Finance (Interim PAO) |
| 2024-02-23 | Parisi Samuel Joseph |
|
1.03 | 29.57 | 是 | VP, Finance (Interim PAO) |
| 2024-02-22 | Brown Iain Michael |
|
11.63 | -- | 是 | SVP, Chief Financial Officer |
| 2024-02-22 | Brown Iain Michael |
|
11.31 | 28.91 | 是 | SVP, Chief Financial Officer |
| 2024-02-22 | Hopkinson Craig C. |
|
11.09 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-22 | Hopkinson Craig C. |
|
10.54 | 28.91 | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-22 | Gaffin David Joseph |
|
16.38 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-22 | Gaffin David Joseph |
|
16.05 | 28.91 | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-22 | Nichols Christian Todd |
|
7.59 | -- | 是 | SVP, Chief Commercial Officer |
| 2024-02-22 | Nichols Christian Todd |
|
7.28 | 28.91 | 是 | SVP, Chief Commercial Officer |
| 2024-02-22 | LANDINE MICHAEL J |
|
28.14 | -- | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-22 | LANDINE MICHAEL J |
|
27.95 | 28.91 | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-22 | Jackson Blair Curtis |
|
15.72 | -- | 是 | EVP, Chief Operating Officer |
| 2024-02-22 | Jackson Blair Curtis |
|
15.29 | 28.91 | 是 | EVP, Chief Operating Officer |
| 2024-02-22 | Parisi Samuel Joseph |
|
0.96 | -- | 是 | VP, Finance (Interim PAO) |
| 2024-02-22 | Parisi Samuel Joseph |
|
0.87 | 28.91 | 是 | VP, Finance (Interim PAO) |
| 2024-02-18 | Gaffin David Joseph |
|
15.41 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-18 | Gaffin David Joseph |
|
15.22 | 32.18 | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-18 | Gaffin David Joseph |
|
15.94 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-18 | Gaffin David Joseph |
|
15.64 | 30.39 | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-18 | Brown Iain Michael |
|
10.81 | -- | 是 | SVP, Chief Financial Officer |
| 2024-02-18 | Brown Iain Michael |
|
10.62 | 32.18 | 是 | SVP, Chief Financial Officer |
| 2024-02-18 | Brown Iain Michael |
|
11.09 | -- | 是 | SVP, Chief Financial Officer |
| 2024-02-18 | Brown Iain Michael |
|
10.92 | 30.39 | 是 | SVP, Chief Financial Officer |
| 2024-02-18 | Nichols Christian Todd |
|
6.82 | -- | 是 | SVP, Chief Commercial Officer |
| 2024-02-18 | Nichols Christian Todd |
|
6.63 | 32.18 | 是 | SVP, Chief Commercial Officer |
| 2024-02-18 | Nichols Christian Todd |
|
7.02 | -- | 是 | SVP, Chief Commercial Officer |
| 2024-02-18 | Nichols Christian Todd |
|
6.88 | 30.39 | 是 | SVP, Chief Commercial Officer |
| 2024-02-18 | Parisi Samuel Joseph |
|
0.59 | -- | 是 | VP, Finance (Interim PAO) |
| 2024-02-18 | Parisi Samuel Joseph |
|
0.52 | 32.18 | 是 | VP, Finance (Interim PAO) |
| 2024-02-18 | Parisi Samuel Joseph |
|
0.71 | -- | 是 | VP, Finance (Interim PAO) |
| 2024-02-18 | Parisi Samuel Joseph |
|
0.65 | 30.39 | 是 | VP, Finance (Interim PAO) |
| 2024-02-18 | LANDINE MICHAEL J |
|
27.19 | 32.18 | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-18 | LANDINE MICHAEL J |
|
27.73 | -- | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-18 | LANDINE MICHAEL J |
|
27.57 | 30.39 | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-18 | LANDINE MICHAEL J |
|
27.32 | -- | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-18 | Hopkinson Craig C. |
|
9.68 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-18 | Hopkinson Craig C. |
|
9.29 | 32.18 | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-18 | Hopkinson Craig C. |
|
10.32 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-18 | Hopkinson Craig C. |
|
9.86 | 30.39 | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-18 | Jackson Blair Curtis |
|
14.88 | -- | 是 | EVP, Chief Operating Officer |
| 2024-02-18 | Jackson Blair Curtis |
|
14.50 | 32.18 | 是 | EVP, Chief Operating Officer |
| 2024-02-18 | Jackson Blair Curtis |
|
14.96 | -- | 是 | EVP, Chief Operating Officer |
| 2024-02-18 | Jackson Blair Curtis |
|
14.76 | 30.39 | 是 | EVP, Chief Operating Officer |
| 2024-02-15 | LAURENCIN CATO T |
|
1.52 | 31.85 | 是 | -- |
| 2024-02-15 | LAURENCIN CATO T |
|
1.79 | 22.52 | 是 | -- |
| 2024-02-10 | Daglio David Angelo Jr. |
|
2.42 | -- | 是 | -- |
| 2024-02-10 | Daglio David Angelo Jr. |
|
2.31 | 27.32 | 是 | -- |
| 2024-02-10 | MCKEON BRIAN P |
|
2.42 | -- | 是 | -- |
| 2024-02-10 | MCKEON BRIAN P |
|
2.31 | 27.32 | 是 | -- |
| 2024-02-08 | LANDINE MICHAEL J |
|
27.19 | -- | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-08 | LANDINE MICHAEL J |
|
26.87 | 26.77 | 是 | SVP, Corp Dev., Alkermes, Inc. |
| 2024-02-08 | POPS RICHARD F |
|
127.14 | -- | 是 | Director and CEO, Alkermes plc |
| 2024-02-08 | POPS RICHARD F |
|
117.97 | 26.77 | 是 | Director and CEO, Alkermes plc |
| 2024-02-08 | Brown Iain Michael |
|
10.99 | -- | 是 | SVP, Chief Financial Officer |
| 2024-02-08 | Brown Iain Michael |
|
10.17 | 26.77 | 是 | SVP, Chief Financial Officer |
| 2024-02-08 | Gaffin David Joseph |
|
15.62 | -- | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-08 | Gaffin David Joseph |
|
14.77 | 26.77 | 是 | EVP, CLO, Alkermes, Inc. |
| 2024-02-08 | Hopkinson Craig C. |
|
10.32 | -- | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-08 | Hopkinson Craig C. |
|
8.79 | 26.77 | 是 | EVP R&D, Chief Medical Officer |
| 2024-02-08 | Nichols Christian Todd |
|
6.99 | -- | 是 | SVP, Chief Commercial Officer |
| 2024-02-08 | Nichols Christian Todd |
|
6.18 | 26.77 | 是 | SVP, Chief Commercial Officer |
| 2024-02-08 | Jackson Blair Curtis |
|
15.10 | -- | 是 | EVP, Chief Operating Officer |
| 2024-02-08 | Jackson Blair Curtis |
|
13.99 | 26.77 | 是 | EVP, Chief Operating Officer |